The ColonCore panel (Burning Rock, Guangzhou, China) was designed to detect the MSI status together with mutations in 36 CRC-related genes (including KRAS, NRAS, BRAF, hereditary CRC genes and other genes related to carcinogenesis and tumour development). This evidence concerns the gene KRAS and colorectal carcinoma.